MedTrace Logo

Diagnostic Study for Differentiating Functional From Organic Diseases in Patients With Lower GIT Symptoms

NCT07016529 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-06-11

No results posted yet for this study

Summary

The study is intended to find a new trusted, cost-effective biomarker for differentiating irritable bowel syndrome from inflammatory bowel disease to decrease the use of unnecessary invasive methods in patients with irritable bowel syndrome

Conditions

  • Irritable Bowel Syndrome (IBS)
  • Inflammatory Bowel Disease (IBD)

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-10
Primary Completion
2025-12-10
Completion
2025-12-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07016529 on ClinicalTrials.gov